Camille Audousset

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.

Journal: Frontiers in pharmacology

Published: July 07, 2025

Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies.

Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies.

Journal: The Lancet. Respiratory medicine

Published: March 27, 2025

Pregnancy and neonatal outcome following in utero exposure to CFTR modulators: A multicentre prospective case series.

Pregnancy and neonatal outcome following in utero exposure to CFTR modulators: A multicentre prospective case series.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: March 18, 2025

Cystic fibrosis: influence of CFTR variants on epididymal sperm recovery and ICSI results.

Cystic fibrosis: influence of CFTR variants on epididymal sperm recovery and ICSI results.

Journal: Reproductive biomedicine online

Published: March 03, 2025

Preliminary proposals for the follow-up of infants born to mothers with cystic fibrosis treated with CFTR modulators during the first two years of life.

Preliminary proposals for the follow-up of infants born to mothers with cystic fibrosis treated with CFTR modulators during the first two years of life.

Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Published: October 22, 2024

Elexacaftor/tezacaftor/ivacaftor induced liver enzymes abnormalities in breastfed infants: A series of 3 cases.

Elexacaftor/tezacaftor/ivacaftor induced liver enzymes abnormalities in breastfed infants: A series of 3 cases.

Journal: Therapie

Published: July 08, 2024

The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study.

The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study.

Journal: The Lancet. Respiratory medicine

Published: April 11, 2024

Local receptor-interacting protein kinase 2 inhibition mitigates house dust mite-induced asthma.

Local receptor-interacting protein kinase 2 inhibition mitigates house dust mite-induced asthma.

Journal: The European respiratory journal

Published: December 20, 2023

Gathering real-world compassionate data to expand eligibility for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with N1303K or other rare CFTR variants: a viewpoint.

Gathering real-world compassionate data to expand eligibility for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with N1303K or other rare CFTR variants: a viewpoint.

Journal: The European respiratory journal

Published: September 03, 2023

Allergic bronchopulmonary aspergillosis: A multidisciplinary review.

Allergic bronchopulmonary aspergillosis: A multidisciplinary review.

Journal: Journal de mycologie medicale

Published: December 27, 2022

The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant.

The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant.

Journal: The European respiratory journal

Published: December 20, 2022

NOD-like receptors in asthma.

NOD-like receptors in asthma.

Journal: Frontiers in immunology

Published: April 26, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026